Rapid Micro Biosystems, Inc. is a life sciences technology company. The company is headquartered in Lexington, Massachusetts and currently employs 171 full-time employees. The company went IPO on 2021-07-15. Its flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in pharmaceutical manufacturing operations. The company offers four specific applications for testing of microbial contamination: Environmental Monitoring, which tests the manufacturing environment, including circulating air, exposed surfaces, and personnel; Water, which tests any purified water used at any stage of the drug production process, including water for injection; In-Process Bioburden, which tests raw materials, drug substance and in-process product, and Sterility Release offering final testing of finished product to ensure sterility before the product is released for commercial sale.
How did RPID's recent EPS compare to expectations?
The most recent EPS for Rapid Micro Biosystems, Inc is $-0.31, beating expectations of $-0.25.
How did Rapid Micro Biosystems, Inc RPID's revenue perform in the last quarter?
Rapid Micro Biosystems, Inc revenue for the last quarter is $-0.31
What is the revenue estimate for Rapid Micro Biosystems, Inc?
According to 6 of Wall street analyst, the revenue estimate of Rapid Micro Biosystems, Inc range from $8.5M to $7.54M
What's the earning quality score for Rapid Micro Biosystems, Inc?
Rapid Micro Biosystems, Inc has a earning quality score of B+/48.819218. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Rapid Micro Biosystems, Inc report earnings?
Rapid Micro Biosystems, Inc next earnings report is expected in 2026-08-11
What are Rapid Micro Biosystems, Inc's expected earnings?
Rapid Micro Biosystems, Inc expected earnings is $7.75M, according to wall-street analysts.
Did Rapid Micro Biosystems, Inc beat earnings expectations?
Rapid Micro Biosystems, Inc recent earnings of $8.0M beat expectations.